Even after correction for clinically relevant cofounders (age, arterial hypertension, type 2 diabetes and LDL-cholesterol levels), VCAM-1 concentration [HF 1.001, 95% CI (1.0001–1.0018); p = 0.02] remained associated with the presence of PAD. This evidence concerns the gene VCAM1 and peripheral arterial disease.